MURGF:OTO-Muenchener Ruekvr Ges Shs (USD)

COMMON STOCK | Insurance - Reinsurance | OTC Pink

Last Closing

USD 498

Change

+3.03 (+0.61)%

Market Cap

USD 30.65B

Volume

8.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Munchener Ruckversicherungs-Gesellschaft AG provides insurance and reinsurance services. The Company offers reinsurance and primary insurance including health and property-casualty insurance.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-25 )

Largest Industry Peers for Insurance - Reinsurance

Symbol Name Price(Change) Market Cap
SSREY Swiss Re Ltd

-0.13 (-0.37%)

USD 39.84B
HVRRF Hannover Rück SE

N/A

USD 33.93B
SCRYY SCOR PK

+0.03 (+1.45%)

USD 3.91B
CFACY COFACE SA

N/A

USD 2.47B
CNDHF Conduit Holdings Limited

N/A

USD 1.06B
TILCF Till Capital Ltd

N/A

USD 4.37M
PREJF PartnerRe Ltd.

-0.32 (-1.76%)

N/A
HVRRY Hannover Re

+0.34 (+0.73%)

N/A
SZCRF SCOR SE

+0.86 (+3.98%)

N/A
GVFG GEROVA Financial Group Ltd

N/A

N/A

ETFs Containing MURGF

DXGE 0.00 % 0.48 %

N/A

N/A
DXGY:LSE 0.00 % 0.00 %

N/A

N/A
ETSY:LSE 0.00 % 0.00 %

N/A

N/A
ELOW:LSE 0.00 % 0.00 %

N/A

N/A
C002:F 0.00 % 0.00 %

N/A

N/A
C003:F Lyxor DivDAX® (DR) UCITS.. 0.00 % 0.00 %

+0.58 (+1.70%)

USD 0.08B
E903:F Lyxor 1 - DivDAX UCITS ET.. 0.00 % 0.00 %

+1.46 (+1.70%)

N/A
EXSB:F iShares DivDAX UCITS ETF .. 0.00 % 0.00 %

+0.36 (+1.70%)

N/A
XGLF:F db x-trackers MSCI GCC Se.. 0.00 % 0.00 %

-0.02 (1.70%)

USD 0.02B
C002:XETRA 0.00 % 0.00 %

N/A

N/A
C003:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.50 (+1.70%)

USD 0.08B
E903:XETRA Lyxor 1 DivDAX (DR) UCITS.. 0.00 % 0.00 %

+2.72 (+1.70%)

USD 0.07B
EXSB:XETRA iShares DivDAX UCITS ETF .. 0.00 % 0.00 %

+0.31 (+1.70%)

USD 0.57B
UIM8:XETRA 0.00 % 0.00 %

N/A

N/A
VDXX:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD 0.11B
X503:XETRA 0.00 % 0.00 %

N/A

N/A
XGLF:XETRA db x-trackers MSCI GCC Se.. 0.00 % 0.00 %

-0.07 (1.70%)

USD 0.02B
CAPE:LSE Ossiam Shiller Barclays C.. 0.00 % 0.00 %

+9.10 (+1.70%)

USD 0.17B

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Reinsurance) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.87% 91% A- 76% C+
Dividend Return 3.04% 29% F 60% D-
Total Return 23.92% 91% A- 77% C+
Trailing 12 Months  
Capital Gain 38.69% 90% A- 83% B
Dividend Return 3.49% 29% F 47% F
Total Return 42.18% 90% A- 83% B
Trailing 5 Years  
Capital Gain 96.53% 90% A- 87% B+
Dividend Return 19.23% 57% F 63% D
Total Return 115.76% 90% A- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 16.45% 73% C 63% D
Dividend Return 19.81% 73% C 62% D
Total Return 3.36% 44% F 58% F
Risk Return Profile  
Volatility (Standard Deviation) 25.90% 55% F 78% C+
Risk Adjusted Return 76.48% 91% A- 96% N/A
Market Capitalization 30.65B 100% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector